Wegovy weight loss after 1 month: what actually happens in the first four weeks

You've just started your first pen, here's what month one looks like

Picture this: you've received your first Wegovy pen, read the instructions, done your first injection. The dose is 0.25mg once a week. You're waiting to feel something significant, and by week two you notice you're leaving food on your plate more often. You're not particularly hungry at your usual lunch time. That's not nothing, that's semaglutide beginning to work on the GLP-1 receptors involved in appetite signalling and the rate at which your stomach empties.

What isn't happening yet is aggressive weight loss. The 0.25mg dose is the entry point into the titration schedule, 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, then 2.4mg, each step roughly four weeks apart as directed by your prescriber. Month one is step one. The early weeks are about your body learning to tolerate the medicine well enough to reach the doses where the larger effects show up.

A common misconception worth setting down: many people assume that if they haven't lost a stone by week four, Wegovy isn't working for them. It almost never works that way. The STEP 1 trial (the pivotal study published in the New England Journal of Medicine) followed participants for 68 weeks and recorded an average body-weight reduction of around 15% at the 2.4mg maintenance dose. That figure is an endpoint, built up across the full treatment period. Week four contributes to it; it isn't the whole picture. You can read more about what Wegovy weight loss looks like by month six once the full maintenance dose is established.

What a realistic month-one result looks like, and why it differs so much between people

Early data and clinical experience suggest that in the first four weeks, many people on Wegovy lose somewhere in the range of 1–3 kg, though some see a little more and some see less. That range reflects how much individual biology varies. Starting weight matters: someone with a higher starting BMI may see a larger absolute loss early on, even at the same dose. Diet and activity changes made alongside treatment matter. How sensitive someone's gut is to semaglutide in the first weeks matters too. If you want a closer look at what Wegovy weight loss in month one tends to involve for most people, including what's typical and what isn't, that page breaks it down in more detail.

The NHS explains that semaglutide works by mimicking GLP-1, a hormone that acts on the brain's appetite centres, slows gastric emptying and reduces the drive to eat, you can read a clear patient-level explanation on the NHS semaglutide medicines page. At 0.25mg, that process is starting, not peaking. The prescription schedule is deliberately unhurried because tolerability (particularly around nausea) improves when the dose increases are spaced out.

If you're comparing yourself to someone who seems to have lost more quickly, it's worth remembering that social media stories tend to feature outliers. Averages are built from the full distribution, not the most striking case. Curious about the longer arc? The picture at three months on Wegovy starts to show more meaningful progress as the dose climbs.

Side effects in the first four weeks: what to expect and when to get help

Month one is when side effects are most likely to make themselves known. The GI effects (nausea, constipation, some people experience loose stools or an unsettled stomach) are the most commonly reported, and they tend to peak in the days after each new injection, then ease off before the next one. Most people find they settle noticeably as the weeks pass and the body adapts.

Practical things that help: eating smaller portions rather than large meals, avoiding very rich or fatty foods in the early weeks, staying well hydrated, and not rushing back to previous portion sizes if appetite is suppressed. These aren't rules your prescriber may not personalise, always follow the guidance in your Patient Information Leaflet and any specific advice from your clinical team.

A small number of people experience more persistent or severe symptoms. Severe stomach pain that radiates to the back, with or without vomiting, needs prompt medical assessment, this can be a sign of acute pancreatitis, an infrequent but serious side effect that the MHRA specifically flagged in a Drug Safety Update for GLP-1 medicines. Any side effect you're concerned about should be discussed with your prescriber or GP. You can also report side effects directly through the Yellow Card scheme.

If you'd like to understand the full side-effect and effectiveness picture across the treatment period, the Wegovy overview covers the licensed schedule in detail.

What to do if month one feels discouraging, and when to ask for support

A slow start doesn't mean the treatment isn't working. The body takes time to respond to semaglutide at a low dose, and the meaningful results in clinical trials accumulated steadily over many months of treatment at higher doses. That's the shape of how this medicine works, not a fast drop, then a plateau, but a gradual consistent loss that adds up. For those wondering what the next stage brings, Wegovy weight loss after two months gives a useful indication of how progress typically develops once the first dose increase has taken effect.

If you're already considering what comes next in terms of costs and planning, it's worth understanding how Wegovy is priced in the UK across the full titration period. Knowing the longer-term picture early on helps people make informed decisions about whether to continue.

Side effects that aren't improving after a few weeks, unexpectedly slow progress, or questions about whether your dose increase is due, these are all worth raising with your prescriber. At nume, aftercare is available seven days a week precisely because questions come up between doses, not only at the point of ordering. If you're thinking about starting or want your situation assessed, checking your eligibility is the first step.